List of Zuragard drug patents

Zuragard is owned by Zurex Pharma.

Zuragard contains Isopropyl Alcohol.

Zuragard has a total of 7 drug patents out of which 0 drug patents have expired.

Zuragard was authorised for market use on 26 April, 2019.

Zuragard is available in solution;topical dosage forms.

Zuragard can be used as use as an antiseptic for the preparation of a patient's skin prior to surgery.

The generics of Zuragard are possible to be released after 24 April, 2036.

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9011897 ZUREX PHARMA Catheter lock solution comprising citrate and a paraben
Feb, 2025

(2 years from now)

US8226971 ZUREX PHARMA Catheter lock solution comprising citrate and a paraben
May, 2025

(2 years from now)

US8703828 ZUREX PHARMA Antimicrobial compositions and methods of use
May, 2028

(5 years from now)

US9629368 ZUREX PHARMA Antimicrobial compositions and methods of use
May, 2028

(5 years from now)

US8389583 ZUREX PHARMA Antimicrobial compositions and methods of use
Aug, 2029

(6 years from now)

US10688291 ZUREX PHARMA Medical skin applicator apparatus
Dec, 2034

(11 years from now)

US9844654 ZUREX PHARMA Medical skin applicator apparatus
Apr, 2036

(13 years from now)

Exclusivity Exclusivity Expiration
New Product (NP) Apr 26, 2022
M Jun 24, 2024

Drugs and Companies using ISOPROPYL ALCOHOL ingredient

Market Authorisation Date: 26 April, 2019

Treatment: Use as an antiseptic for the preparation of a patient's skin prior to surgery

Dosage: SOLUTION;TOPICAL

More Information on Dosage

availability in other generic markets.

Click on the highlighted region to filter.

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in